Authors:
Sandborn, WJ
Feagan, BG
Hanauer, SB
Present, DH
Sutherland, LR
Kamm, MA
Wolf, DC
Baker, JP
Hawkey, C
Archambault, A
Bernstein, CN
Novak, C
Heath, PK
Targan, SR
Citation: Wj. Sandborn et al., An engineered human antibody to TNF (CDP571) for active Crohn's disease: Arandomized double-blind placebo-controlled trial, GASTROENTY, 120(6), 2001, pp. 1330-1338
Authors:
Danesh, J
Whincup, P
Walker, M
Lennon, L
Thomson, A
Appleby, P
Hawkey, C
Atherton, JC
Citation: J. Danesh et al., High prevalence of potentially virulent strains of Helicobacter pylori in the general male British population, GUT, 47(1), 2000, pp. 23-25
Authors:
Whincup, P
Danesh, J
Walker, M
Lennon, L
Thomson, A
Appleby, P
Hawkey, C
Atherton, J
Citation: P. Whincup et al., Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men, CIRCULATION, 101(14), 2000, pp. 1647-1652
Authors:
Hawkey, C
Laine, L
Simon, T
Beaulieu, A
Maldonado-Cocco, J
Acevedo, E
Shahane, A
Quan, H
Bolognese, J
Mortensen, E
Citation: C. Hawkey et al., Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis - A randomized, double-blind, placebo-controlled trial, ARTH RHEUM, 43(2), 2000, pp. 370-377